(Q37345155)

19 August 2017

1 reference

title

Pulmonary complications of tumor necrosis factor-targeted therapy (English)

1 reference

19 August 2017

Krishna Thavarajah

1

1 reference

19 August 2017

Peggy Wu

2

1 reference

19 August 2017

Elisa J Rhew

3

1 reference

19 August 2017

Anjana K Yeldandi

4

1 reference

19 August 2017

David W Kamp

5

1 reference

19 August 2017

7 February 2009

1 reference

19 August 2017

1 reference

19 August 2017

103

1 reference

19 August 2017

5

1 reference

19 August 2017

661-669

1 reference

Autoimmune diseases induced by TNF-targeted therapies

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Targeting TNF-alpha: a novel therapeutic approach for asthma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Biological and clinical effects of anti-TNFalpha treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Development of sarcoidosis during etanercept therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Biological agents for rheumatoid arthritis: targeting both physical function and structural damage

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Adalimumab (HUMIRA): a review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

The divergent role of tumor necrosis factor receptors in infectious diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

6 September 2017

The rheumatoid nodule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Lung injury linked to etanercept therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Autoimmune Diseases Induced by TNF-Targeted Therapies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Pulmonary sarcoidosis developing during infliximab therapy

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743303

Granulomatous lung disease occurring during etanercept treatment

3 December 2018

1 reference

12 December 2020

Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis

1 reference

12 December 2020

Interstitial pneumonitis associated with infliximab therapy

1 reference

12 December 2020

Sarcoid-like granulomatous disease following etanercept treatment for RA

1 reference

12 December 2020

Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists

1 reference

12 December 2020

Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept

1 reference

12 December 2020

Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis

1 reference

12 December 2020

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

12 December 2020

Pulmonary rheumatoid nodules in an etanercept-treated patient

1 reference

12 December 2020

Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis

1 reference

12 December 2020

Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy

1 reference

12 December 2020

Severe interstitial pneumonitis associated with infliximab therapy

1 reference

12 December 2020

Infliximab-induced SLE-like syndrome involving the lung and pleura

1 reference

12 December 2020

Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy

1 reference

12 December 2020

10.1016/J.RMED.2009.01.002

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference